Back
FCVB 2024 Premium Access

Leukemia inhibitory factor receptor inhibition reduces stenosis grade and total serum cholesterol levels in a mouse model for atherosclerosis

Session: Immune modulation in atherosclerosis
Topic: Drugs, Drug Targets
Speaker: Ms E. Hemme (Leiden, NL)
Event: Frontiers in CardioVascular Biomedicine 2024

Congress Presentation

About the speaker

Ms Esmeralda Hemme

Leiden Academic Center for Drug Research, Leiden (Netherlands (The))
0 follower

4 more presentations in this session

Exploring PD-1+ and tissue resident memory T cells in atherosclerotic diseases

Speaker: Miss K. Van Dijk (Leiden, NL)

Access
Abstract
Thumbnail

Liraglutide prevents hyperglycemia-induced senescence and proinflammatory monocyte differentiation in CD34+ hematopoietic stem cells

Speaker: Doctor G. Damiano (Milan, IT)

Access
Abstract
Thumbnail

Impact of immune system humanization on atherosclerosis in dyslipidemic immunocompromised mice

Speaker: Doctor F. Bonacina (Milan, IT)

Access
Abstract
Thumbnail

The novel bispecific anti-NLRP3 inflammasome antibody InflamAb inhibits atherosclerosis in apolipoprotein E-deficient mice

Speaker: Ms L. Delfos (Leiden, NL)

Access
Abstract
Thumbnail

Access the full session

Immune modulation in atherosclerosis

Speakers: Ms E. Hemme, Miss K. Van Dijk, Doctor G. Damiano, Doctor F. Bonacina, Ms L. Delfos
Access
Thumbnail

About the event

Image

Frontiers in CardioVascular Biomedicine 2024

12 April - 14 April 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb